Cargando…
The clinical features and outcomes of Tolosa-Hunt syndrome
BACKGROUND: The objective of this study was to investigate the clinical features and outcomes of Tolosa-Hunt syndrome (THS). METHODS: A retrospective review of the medical records was performed on patients with THS between March 2016 and January 2020. A total of eleven patients fulfilling the Intern...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161661/ https://www.ncbi.nlm.nih.gov/pubmed/34044807 http://dx.doi.org/10.1186/s12886-021-02007-0 |
_version_ | 1783700547793059840 |
---|---|
author | Kim, Hyuna Oh, Shin Yeop |
author_facet | Kim, Hyuna Oh, Shin Yeop |
author_sort | Kim, Hyuna |
collection | PubMed |
description | BACKGROUND: The objective of this study was to investigate the clinical features and outcomes of Tolosa-Hunt syndrome (THS). METHODS: A retrospective review of the medical records was performed on patients with THS between March 2016 and January 2020. A total of eleven patients fulfilling the International Classification of Headache Disorders (ICHD-3 beta) diagnostic criteria for THS were included in this study. RESULTS: The average age of the patients with THS was 57.18 ± 15.32 years and the mean duration of recovery was 26.91 ± 24.35 days. All eleven patients had orbital or periorbital pain as the first symptom followed by diplopia. Ptosis was found in five patients (45.45 %) in the involved eye. Sixth cranial nerve (CN) palsy was most common (eight cases, 72.73 %), followed by third and fourth CN palsy (five cases, 45.45 %, respectively), optic neuritis (two cases, 18.18 %), and trigeminal nerve and facial nerve palsy (one case, 9.09 %, respectively). One patient with optic neuritis failed to recover visual acuity and the other ten patients completely recovered their ocular motor limitation. All patients were initially treated with steroids. One patient relapsed after five weeks and one patient had a history of THS five years earlier. CONCLUSIONS: THS responded well to steroid treatment, but if it was accompanied by optic neuritis as optic nerve involvement, we suggest follow-up with high dose steroid treatment especially was important. |
format | Online Article Text |
id | pubmed-8161661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81616612021-06-01 The clinical features and outcomes of Tolosa-Hunt syndrome Kim, Hyuna Oh, Shin Yeop BMC Ophthalmol Research BACKGROUND: The objective of this study was to investigate the clinical features and outcomes of Tolosa-Hunt syndrome (THS). METHODS: A retrospective review of the medical records was performed on patients with THS between March 2016 and January 2020. A total of eleven patients fulfilling the International Classification of Headache Disorders (ICHD-3 beta) diagnostic criteria for THS were included in this study. RESULTS: The average age of the patients with THS was 57.18 ± 15.32 years and the mean duration of recovery was 26.91 ± 24.35 days. All eleven patients had orbital or periorbital pain as the first symptom followed by diplopia. Ptosis was found in five patients (45.45 %) in the involved eye. Sixth cranial nerve (CN) palsy was most common (eight cases, 72.73 %), followed by third and fourth CN palsy (five cases, 45.45 %, respectively), optic neuritis (two cases, 18.18 %), and trigeminal nerve and facial nerve palsy (one case, 9.09 %, respectively). One patient with optic neuritis failed to recover visual acuity and the other ten patients completely recovered their ocular motor limitation. All patients were initially treated with steroids. One patient relapsed after five weeks and one patient had a history of THS five years earlier. CONCLUSIONS: THS responded well to steroid treatment, but if it was accompanied by optic neuritis as optic nerve involvement, we suggest follow-up with high dose steroid treatment especially was important. BioMed Central 2021-05-27 /pmc/articles/PMC8161661/ /pubmed/34044807 http://dx.doi.org/10.1186/s12886-021-02007-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kim, Hyuna Oh, Shin Yeop The clinical features and outcomes of Tolosa-Hunt syndrome |
title | The clinical features and outcomes of Tolosa-Hunt syndrome |
title_full | The clinical features and outcomes of Tolosa-Hunt syndrome |
title_fullStr | The clinical features and outcomes of Tolosa-Hunt syndrome |
title_full_unstemmed | The clinical features and outcomes of Tolosa-Hunt syndrome |
title_short | The clinical features and outcomes of Tolosa-Hunt syndrome |
title_sort | clinical features and outcomes of tolosa-hunt syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161661/ https://www.ncbi.nlm.nih.gov/pubmed/34044807 http://dx.doi.org/10.1186/s12886-021-02007-0 |
work_keys_str_mv | AT kimhyuna theclinicalfeaturesandoutcomesoftolosahuntsyndrome AT ohshinyeop theclinicalfeaturesandoutcomesoftolosahuntsyndrome AT kimhyuna clinicalfeaturesandoutcomesoftolosahuntsyndrome AT ohshinyeop clinicalfeaturesandoutcomesoftolosahuntsyndrome |